DeutschNewstral
Article
The Hindu on 2022-04-26 18:37
Corbevax, Covaxin get drug regulator nod for use in children
Related news
Corbevax, Covaxin get emergency use nod in kids under 12The Times of India- Corbevax gets nod as booster after two doses of Covishield or CovaxinThe Hindu
- Corbevax gets DCGI nod for use as booster jabThe Times of India
- Live: Corbevax gets nod as booster after Covishield, CovaxinThe Times of India
- Covaxin granted emergency use nod for kids: here's what we knowThe Times of India
- Covishield, Covaxin granted conditional market nodThe Times of India
- Drug Controller General approves Covishield and Covaxin in India for ‘emergency use’The Hindu
- Panel OKs Corbevax for 5-11 group; final nod ‘soon’The Times of India
- DCGI nod for Covaxin human trialsThe Hindu
- Drug regulator cautions against over-the-counter use of ranitidineThe Hindu
- Covid-19: PM Modi pushed for Covaxin nod at G20 meet with WHO chiefThe Times of India
- Reports misleading, Covaxin nod not a rush job: GovtThe Times of India
- Biocon’s psoriasis drug gets DCGI nod for use in COVID-19 patientsThe Hindu
- Decision on Covaxin nod likely in 4-6 weeks: WHOThe Hindu
- Canada yet to recognise Covaxin even after WHO nodThe Times of India
- Quick Edit: Govt must help Covaxin get WHO nodThe Times of India
- Covaxin does not have WHO’s emergency use listing for use in childrenThe Hindu
- MNCs tried to scuttle WHO nod for Covaxin: CJI RamanaThe Times of India
- WHO grants Covaxin ‘Emergency Use Listing’The Hindu